| Home | E-Submission | Sitemap | Contact Us |  
J Korean Cancer Assoc > Volume 27(4); 1995 > Article
Journal of the Korean Cancer Association 1995;27(4): 671-680.
C3H 마우스 섬유육종 온열치료시 Hydralazine 이 미치는 영향
박우윤, 하성환, 박찬일
The Effect of Hydralazine on Hyperthermic Treatment of C3H Mouse Fibrosarcoma
Woo Yoon Park, Sung Whan Ha, Charn Il Park
Hypoxic cells comprise l0~20% of tumor cells and are more sensitive to hyperthermia. By decreasing tumor blood flow artificially and thus increasing the hypoxic fraction in the tumor, the cytotoxic effect of hyperthermia can be increased. Hydralazine is an antihypertensive drug and its main mechanism is relaxation of the vascular smooth muscle of arterioles rather than veins. Administration of hydralazine causes a decrease in vascular resistance and an increase in blood flow in normal tissue, but since the vasculature of tumor is not responsive to such a drug, blood flow in tumors is decreased because of steal phenomenon. Thus the hypoxic fraction in the tumor is increased, and the tumor becomes more sensitive to hyperthermia. Therefore, to evaluate the hydralazine effect on hyperthermia, the tumor growth delay was investigated and the change in the hynoxic fraction of the tumor was estimated using C3H mouse fibrosarcoma(FSaII) with hypoxic fractions af usual range. In 6 mm FSaII tumors grow- ing in the dorsum of the foot, administration af 5 or l0 mg/kg of hydralazine was followed by 43`C, hyperthermia for 60 minutes. Tumor growth times (TGT) to reach a tumor volume of 500 mm(2) were 7.11+-0.84 days and 7.44+- 1.13 days for controls and 10 mg/kg of hydralazine only. TGTs for hyperthermia alone and administration of 5 or 10 mg/kg of hydralazine followed by hyperthermia were 10.34+-2.17 days, 13.38+-1.82 days and 14.47+- 0.67 days, respectively. Elongation of tumor growth delay by administration of 5 or l0 mg/kg of hydralazine in addition to hyperthermia were statistically significant (0.025<p<0.05 and p<0.005, respectively). Tumor control radiation doses (TCD) were 69.6 (66.8-72.5) Gy for radiation alone, 80.9(76.2-85.7) Gy for radiation after administration of hydralazine (10mg/kg) and 81.7 (77.7-86.9) Gy for radiation under clamp hypoxia. The hypoxic fraction estimated from the TCD 's was 10.6% for controls and this was markedly increased to 86.2% by administration of hydralazine. From the above results it was confirmed that the cytotoxic effect of hyperthermia was enhanced significantly by administration of hydralazine as a result of marked increase in the hypoxic fraction in the tumor.
Key words: C3H mouse fibrosarcoma, Hydralazine, Hyperthermia, Hypoxic fraction
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI